Joel Block to Antirheumatic Agents
This is a "connection" page, showing publications Joel Block has written about Antirheumatic Agents.
Connection Strength
1.963
-
Tuberculosis infections and tumor necrosis factor alpha antagonists. Am J Ther. 2013 Jan; 20(1):73-8.
Score: 0.399
-
Safety of etanercept in patients at high risk for mycobacterial tuberculosis infections. J Rheumatol. 2009 May; 36(5):914-7.
Score: 0.307
-
Rheumatoid arthritis: beyond tumor necrosis factor-alpha antagonists, B cell depletion, and T cell blockade. Am J Ther. 2008 Jan-Feb; 15(1):53-8.
Score: 0.282
-
Etanercept therapy in patients with a positive tuberculin skin test. Clin Exp Rheumatol. 2007 Sep-Oct; 25(5):743-5.
Score: 0.275
-
Drug-induced systemic lupus erythematosus associated with etanercept therapy. Lancet. 2002 Feb 16; 359(9306):579-80.
Score: 0.188
-
Health Disparities Among Hispanics With Rheumatoid Arthritis: Delay in Presentation to Rheumatologists Contributes to Later Diagnosis and Treatment. J Clin Rheumatol. 2020 Oct; 26(7):279-284.
Score: 0.171
-
Hydroxychloroquine and retinal safety. Lancet. 1998 Mar 14; 351(9105):771.
Score: 0.143
-
Absence of transaminase elevation during concomitant methotrexate and isoniazid therapy. J Rheumatol. 2009 Sep; 36(9):2127.
Score: 0.079
-
New therapeutic approaches for spondyloarthritis. Curr Opin Rheumatol. 2007 May; 19(3):259-64.
Score: 0.067
-
Rare infection in patient with rheumatoid arthritis treated with adalimumab. BMJ Case Rep. 2019 Nov 21; 12(11).
Score: 0.040
-
Efficacy of tacrolimus in rheumatoid arthritis patients who have been treated unsuccessfully with methotrexate: a six-month, double-blind, randomized, dose-ranging study. Arthritis Rheum. 2002 Aug; 46(8):2020-8.
Score: 0.012